Health Condition 1: J459- Other and unspecified asthma
Conditions
Interventions
Intervention1: Habb-e-Sadar: Two tablets to be taken orally with water twice daily for 6 weeks
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Males and females of 18-65 years. 2. Patients of Bronchial Asthma for at least 3 months presenting with at least one of the following symptoms: Wheeze Shortness of breath Chest tightness and cough that vary over time and in intensity, Expiratory airflow limitation as suggested by a decreased FEV1 3. Objective evidence for reversible airway obstruction (=12% and =200 mL change in FEV1 and/or a 25% and 60 L/min change in PEFR) either spontaneously or after treatment. 4. Patients with Asthma Control Questionnaire Score more than 1.5
Exclusion criteria
Exclusion criteria: 1. FEV1/FVC ratio less than 50%. 2. Pregnant and lactating mother 3. Patient with other Respiratory Tract Infections, tuberculosis and malignancy. 4. Patient of Presence of chronic cough with expectoration for 2-3 months in each of 2 successive years. 5. Patient with co-morbidities, Diabetes Mellitus, Hepatic and Renal Insufficiency. 6. Patients with Tobacco Smoking. 7. Patient with regular use of oral or systemic corticosteroids for conditions other than Asthma.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of the study drug in the treatment of mild to moderate Zeeq un Nafas (Bronchial Asthma) will be assessed on the basis of Absolute Eosinophil Count (AEC), IgE, Spirometory test, FeNO test and improvement in the Asthma Control Questionnaire (ACQ).Timepoint: At baseline and 2, 4, 6 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and 6 weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed